Literature DB >> 8328574

Anxious and nonanxious depression.

R T Joffe1, R M Bagby, A Levitt.   

Abstract

The authors used the anxiety summary score described by Clayton and associates to assess anxious and nonanxious subtypes of depression in a group of 134 outpatients with major depression. Patients with anxious depression were only slightly less likely to respond to their first tricyclic antidepressant than patients with nonanxious depression. When functional severity or symptom severity was controlled for, this differential treatment response did not hold.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8328574     DOI: 10.1176/ajp.150.8.1257

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  21 in total

1.  What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?

Authors:  Jackie K Gollan; Maurizio Fava; Benji Kurian; Stephen R Wisniewski; A John Rush; Ella Daly; Sachiko Miyahara; Madhukar H Trivedi
Journal:  Depress Anxiety       Date:  2011-12-06       Impact factor: 6.505

Review 2.  The underlying neurobiology of key functional domains in young people with mood and anxiety disorders: a systematic review.

Authors:  Frank Iorfino; Ian B Hickie; Rico S C Lee; Jim Lagopoulos; Daniel F Hermens
Journal:  BMC Psychiatry       Date:  2016-05-23       Impact factor: 3.630

3.  Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats.

Authors:  Gregory V Carr; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-04-06       Impact factor: 4.530

4.  Outcomes of acute phase cognitive therapy in outpatients with anxious versus nonanxious depression.

Authors:  Jasper A J Smits; Abu Minhajuddin; Michael E Thase; Robin B Jarrett
Journal:  Psychother Psychosom       Date:  2012-03-03       Impact factor: 17.659

5.  Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder.

Authors:  Richard Musil; Florian Seemüller; Sebastian Meyer; Ilja Spellmann; Mazda Adli; Michael Bauer; Klaus-Thomas Kronmüller; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Robert Fisher; Wolfgang Gaebel; Rebecca Schennach; Hans-Jürgen Möller; Michael Riedel
Journal:  Int J Methods Psychiatr Res       Date:  2017-06-14       Impact factor: 4.035

Review 6.  Psychosocial and clinical predictors of response to pharmacotherapy for depression.

Authors:  R Michael Bagby; Andrew G Ryder; Carolina Cristi
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

Review 7.  Anxious depression: clinical features and treatment.

Authors:  Sanjai Rao; Sidney Zisook
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

Review 8.  Neurobiology of anxious depression: a review.

Authors:  Dawn F Ionescu; Mark J Niciu; Daniel C Mathews; Erica M Richards; Carlos A Zarate
Journal:  Depress Anxiety       Date:  2013-03-11       Impact factor: 6.505

9.  Comorbid anxiety increases cognitive control activation in Major Depressive Disorder.

Authors:  Natania A Crane; Lisanne M Jenkins; Catherine Dion; Kortni K Meyers; Anne L Weldon; Laura B Gabriel; Sara J Walker; David T Hsu; Douglas C Noll; Heide Klumpp; K Luan Phan; Jon-Kar Zubieta; Scott A Langenecker
Journal:  Depress Anxiety       Date:  2016-07-25       Impact factor: 6.505

10.  Reducing the Burden of Difficult-to-Treat Major Depressive Disorder: Revisiting Monoamine Oxidase Inhibitor Therapy.

Authors:  Larry Culpepper
Journal:  Prim Care Companion CNS Disord       Date:  2013-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.